北京红太阳药业

Beijing Hongtaiyang Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs. As a key subsidiary of the Red Sun Group, the company focuses on therapeutic areas such as neurology, gastroenterology, and infectious diseases. Its flagship product is Edaravone, a free radical scavenger used for the treatment of acute ischemic stroke. The company operates large-scale, GMP-certified manufacturing facilities in Beijing's Huairou District. Beijing Hongtaiyang maintains a robust portfolio of generic medications and is a significant supplier to the Chinese domestic hospital market. The firm is recognized as a National High-tech Enterprise for its contributions to pharmaceutical innovation and production.